Breast cancer brain metastases genomic profiling identifies alterations targetable by immune-checkpoint and PARP inhibitors
Athina Giannoudis(University of Liverpool), Carlo Palmieri(University of Liverpool)
Cited by 8
Related Papers
Expert opinion on the use of anthracyclines in patients with advanced breast cancer at cardiac risk
|Annals of Oncology|2009|198
What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? A harmonised, global longitudinal observational study protocol
|BMJ Open|2021|105
Fibroblast growth factor 7, secreted by breast fibroblasts, is an interleukin-1beta-induced paracrine growth factor for human breast cells
|Journal of Endocrinology|2003|62
Genomic profiling using the UltraSEEK panel identifies discordancy between paired primary and breast cancer brain metastases and an association with brain metastasis-free survival
|Breast Cancer Research and Treatment|2021|16